A&H Focal Inc.

Complete recall history across all FDA and CPSC categories — 21 total recalls

A&H Focal Inc. appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (21)

FDA drug safety enforcement actions by A&H Focal Inc.

Date Product Reason Class
Mar 7, 2017 MACA gold tablets, 6800 mg, 10-count bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 STREE OVERLORD capsules, 3800 mg, 4-count bottle, labeling is in foreign lang... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class II
Mar 7, 2017 GERMANY NIUBIAN tablets, 3000mg, 10-count bottle, labeling is in foreign lang... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 MAX MAN capsules, 3000 mg, 6-count bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class II
Mar 7, 2017 HARD TEN DAYS capsules, 4500mg, 6-count bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class II
Mar 7, 2017 GOLD VIGRA capsules, 50mg, 6-count bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 Clalis capsules, 50mg, 6-count bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 Miraculous Evil Root capsules, 1200 mg, 6-count bottle, labeling is in foreig... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 DADIYONGSHI XIANGGANGTIANLONGSHENGWU tablets, 6-count bottle, labeling is in ... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 YANSHIJIAONANG capsules, 2000mg, 8-count bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 Power V8 Viagra tablets, 200mg, 10-Grain bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 Tiger King tablets, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class II
Mar 7, 2017 Black Ant capsules, 4600mg, 4-count blister pack, labeling is in foreign lan... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class II
Mar 7, 2017 LIEN CHAN FOR SEVEN DAYS capsules, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 GERMANY BLACK GOLD tablets, 2800 mg, 8-count bottle, labeling is in foreign l... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 Indian God Lotion Spray Bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found this product to conta... Class III
Mar 7, 2017 Ye Lang Shen capsules, 5000 mg, 8-count bottle, labeling is in foreign language Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class II
Mar 7, 2017 HU HU SHENG WEI capsules, 3000 mg, 2-count bottle, labeling is in foreign lan... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 LANG YI HAO CHAONONGSUOPIAN tablets, 500 mg, 8-count bottle, labeling is in f... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I
Mar 7, 2017 Zhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign lang... Marked Without An Approved NDA/ANDA: FDA analysis found these products to con... Class I

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.